Drawing for MAB3

USPTO serial 79381287

MAB3

Reviewed by CopyMark Law Group

Reg. 7683035Status 700Registered
Filing date
Status date
Registration date
Feb 11, 2025
Examiner
THOMAS, AMY E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAB3?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101United States

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for scientific, industrial, and research use; immunoglobulins being monoclonal antibodies, monoclonal antibodies, and fragments thereof, for scientific, industrial, and research useACTIVE—
005Pharmaceutical, biopharmaceutical and medical preparations, agents and substances, namely, preparations, agents and substances all containing or being monoclonal antibodies for medical purposes for treatment of cancer, oncological diseases and disorders, infectious diseases and disorders, inflammation and diseases, disorders and conditions associated with inflammation, inflammatory diseases and disorders, and neurological diseases and disorders; immunoglobulins being monoclonal antibodies, monoclonal antibodies, and fragments thereof, for medical use; products in the nature of pharmaceutical preparations and medicines containing immunoglobulins being monoclonal antibodies, monoclonal antibodies, and fragments thereof, for use in medicineACTIVE—
042Scientific and technological services, namely, scientific research and design in the field of monoclonal antibodies for medical purposes; scientific research, namely, industrial analysis and research services in the field of monoclonal antibodies for medical purposes; pharmaceutical, medical, scientific and biopharmaceutical research and development in the field of monoclonal antibodies for medical purposes; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 28, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 28, 2025FIMPFINAL DISPOSITION PROCESSED—
May 11, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 4, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 18, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 18, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 24, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 28, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Nov 22, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 20, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 20, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 20, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 20, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 20, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 20, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2024RFNTREFUSAL PROCESSED BY IB—
May 24, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 24, 2024RFRRREFUSAL PROCESSED BY MPU—
May 15, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 14, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2024DOCKASSIGNED TO EXAMINER—
Oct 31, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 25, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance